申请人:Takeda Chemical Industries, Ltd.
公开号:US04064133A1
公开(公告)日:1977-12-20
Novel cyclohexenone derivatives, which are shown by the general formula ##STR1## wherein each of R.sup.1 and R.sup.2 represents a hydrogen atom, lower alkyl or phenyl group; one of R.sup.3 and R.sup.4 represents a hydrogen atom or lower alkyl group, and the other represents an unsubstituted or substituted phenyl, lower alkyl or aralkyl group, or R.sup.3 and R.sup.4, taken together with the adjacent nitrogen atom, form a 5 to 6-membered heterocyclic ring; one of R.sup.5 and R.sup.6 represents a hydrogen atom or lower alkyl group, and the other represents a lower alkyl, phenyl or aralkyl group, or R.sup.5 and R.sup.6, taken together with the adjacent nitrogen atom, form an unsubstituted or substituted 5 to 6-membered heterocyclic ring, and their pharmaceutically acceptable salts, useful medicines such as analgesics.
新型环己酮衍生物,其通式为##STR1##其中,R.sup.1和R.sup.2分别表示氢原子,低碳基或苯基;R.sup.3和R.sup.4中的一个表示氢原子或低碳基,另一个表示未取代或取代的苯基,低碳基或芳基烷基,或R.sup.3和R.sup.4与相邻的氮原子形成5至6元杂环;R.sup.5和R.sup.6中的一个表示氢原子或低碳基,另一个表示低碳基,苯基或芳基烷基,或R.sup.5和R.sup.6与相邻的氮原子形成未取代或取代的5至6元杂环,以及它们的药学上可接受的盐,是有用的药物,如镇痛剂。